1-219914361-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018713.3(SLC30A10):​c.*1088G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0205 in 152,254 control chromosomes in the GnomAD database, including 84 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 84 hom., cov: 33)
Failed GnomAD Quality Control

Consequence

SLC30A10
NM_018713.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.230

Publications

3 publications found
Variant links:
Genes affected
SLC30A10 (HGNC:25355): (solute carrier family 30 member 10) This gene is highly expressed in the liver and is inducible by manganese. Its protein product appears to be critical in maintaining manganese levels, and has higher specificity for manganese than zinc. Loss of function mutations appear to result in a pleomorphic phenotype, including dystonia and adult-onset parkinsonism. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Mar 2012]
SLC30A10 Gene-Disease associations (from GenCC):
  • cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-219914361-C-T is Benign according to our data. Variant chr1-219914361-C-T is described in ClinVar as Benign. ClinVar VariationId is 295576.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0793 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018713.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC30A10
NM_018713.3
MANE Select
c.*1088G>A
3_prime_UTR
Exon 4 of 4NP_061183.2
SLC30A10
NM_001376929.1
c.*1088G>A
3_prime_UTR
Exon 4 of 4NP_001363858.1A0A8Q3WLF3
SLC30A10
NM_001416004.1
c.*1088G>A
3_prime_UTR
Exon 3 of 3NP_001402933.1B3KR19

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC30A10
ENST00000366926.4
TSL:1 MANE Select
c.*1088G>A
3_prime_UTR
Exon 4 of 4ENSP00000355893.4Q6XR72-4
SLC30A10
ENST00000356609.2
TSL:1
n.*1912G>A
non_coding_transcript_exon
Exon 4 of 4ENSP00000349018.2Q6XR72-3
SLC30A10
ENST00000484079.1
TSL:1
n.2364G>A
non_coding_transcript_exon
Exon 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.0204
AC:
3108
AN:
152136
Hom.:
83
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00362
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.0452
Gnomad ASJ
AF:
0.0182
Gnomad EAS
AF:
0.0851
Gnomad SAS
AF:
0.0591
Gnomad FIN
AF:
0.00821
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0196
Gnomad OTH
AF:
0.0191
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.0205
AC:
3117
AN:
152254
Hom.:
84
Cov.:
33
AF XY:
0.0224
AC XY:
1665
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.00361
AC:
150
AN:
41554
American (AMR)
AF:
0.0455
AC:
696
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0182
AC:
63
AN:
3468
East Asian (EAS)
AF:
0.0859
AC:
445
AN:
5182
South Asian (SAS)
AF:
0.0593
AC:
286
AN:
4822
European-Finnish (FIN)
AF:
0.00821
AC:
87
AN:
10594
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0196
AC:
1332
AN:
68012
Other (OTH)
AF:
0.0189
AC:
40
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
154
309
463
618
772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0187
Hom.:
43
Bravo
AF:
0.0218

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hypermanganesemia with dystonia, polycythemia, and cirrhosis (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
6.0
DANN
Benign
0.77
PhyloP100
0.23

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2275706; hg19: chr1-220087703; API